Diabetes impairs wound healing by Dnmt1-dependent dysregulation of hematopoietic stem cells differentiation towards macrophages by Yan, Jinglian et al.
University of Massachusetts Medical School 
eScholarship@UMMS 
Open Access Articles Open Access Publications by UMMS Authors 
2018-01-02 
Diabetes impairs wound healing by Dnmt1-dependent 
dysregulation of hematopoietic stem cells differentiation towards 
macrophages 
Jinglian Yan 
University of Massachusetts Medical School 
Et al. 
Let us know how access to this document benefits you. 
Follow this and additional works at: https://escholarship.umassmed.edu/oapubs 
 Part of the Cell Biology Commons, Cellular and Molecular Physiology Commons, Endocrine System 
Diseases Commons, Endocrinology Commons, Endocrinology, Diabetes, and Metabolism Commons, 
Genetic Phenomena Commons, and the Nutritional and Metabolic Diseases Commons 
Repository Citation 
Yan J, Tie G, Wang S, Tutto AA, DeMarco N, Khair L, Fazzio TG, Messina LM. (2018). Diabetes impairs 
wound healing by Dnmt1-dependent dysregulation of hematopoietic stem cells differentiation towards 
macrophages. Open Access Articles. https://doi.org/10.1038/s41467-017-02425-z. Retrieved from 
https://escholarship.umassmed.edu/oapubs/3378 
Creative Commons License 
This work is licensed under a Creative Commons Attribution 4.0 License. 
This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in Open Access Articles 
by an authorized administrator of eScholarship@UMMS. For more information, please contact 
Lisa.Palmer@umassmed.edu. 
ARTICLE
Diabetes impairs wound healing by Dnmt1-
dependent dysregulation of hematopoietic stem
cells differentiation towards macrophages
Jinglian Yan1, Guodong Tie1, Shouying Wang1, Amanda Tutto1, Natale DeMarco1, Lyne Khair1,
Thomas G. Fazzio2 & Louis M. Messina1
People with type 2 diabetes mellitus (T2DM) have a 25-fold higher risk of limb loss than non-
diabetics due in large part to impaired wound healing. Here, we show that the impaired
wound healing phenotype found in T2D mice is recapitulated in lethally irradiated wild type
recipients, whose hematopoiesis is reconstituted with hematopoietic stem cells (HSCs) from
T2D mice, indicating an HSC-autonomous mechanism. This impaired wound healing phe-
notype of T2D mice is due to a Nox-2-dependent increase in HSC oxidant stress that
decreases microRNA let-7d-3p, which, in turn, directly upregulates Dnmt1, leading to the
hypermethylation of Notch1, PU.1, and Klf4. This HSC-autonomous mechanism reduces the
number of wound macrophages and skews their polarization towards M1 macrophages.
These ﬁndings reveal a novel inﬂammatory mechanism by which a metabolic disorder
induces an epigenetic mechanism in HSCs, which predetermines the gene expression of
terminally differentiated inﬂammatory cells that controls their number and function.
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About 350 million people worldwide have type 2 diabetesmellitus (T2DM) and this is expected to grow to 440million by 2030. One of the great scourges of diabetes is
the threat of limb loss1. Of the one million people who undergo
leg amputation annually worldwide, 75% are performed on
people who have T2DM2. Impaired wound healing is a hallmark
of the pathophysiology of diabetic foot ulcers and limb amputa-
tions. Despite the magnitude of these clinical consequences, the
mechanism by which T2DM impairs wound healing remains
unknown.
Normal wound healing involves three overlapping phases: (1)
acute inﬂammation, (2) angiogenesis/proliferation, and (3) remo-
deling. Monocytes/macrophages derived from hematopoietic stem
cells (HSCs) represent the most abundant inﬂammatory cell types
during all stages of wound healing3. Monocyte-derived macrophages
can polarize into either M1 (classically activated) or M2 (alter-
natively activated) subtypes in the presence of speciﬁc cues when
recruited into peripheral tissues and wounds4,5. In general, M1
macrophages are characterized by their pro-inﬂammatory function.
M2 macrophages mainly induce angiogenesis and tissue remodeling
in the early phases of wound healing as well as reduce inﬂammation
in the late phase of wound healing. T2DM wounds are characterized
by excessive and prolonged inﬂammation due to the predominant
presence of M1 macrophages6–9. However, the mechanism that
causes this excessive and prolonged inﬂammation remains
unknown10–12.
Epigenetic modiﬁcations, including DNA methylation, histone
modiﬁcation, and small non-coding RNAs, are essential in main-
taining proper lineage commitment and self-renewal of HSCs13–16.
A recent study suggested that T2DM decreases the repressive
histone methylation marker H3K27me3 in the promoter of the IL-
12 gene in bone marrow progenitors. This epigenetic signature is
passed down to terminally differentiated wound-resident macro-
phages in T2DM mice8. Furthermore, we have recently shown that
the mechanism by which hypercholesterolemia increases cancer
incidence involved an HSC-autonomous mechanism. In this cir-
cumstance, hypercholesterolemia-induced HSC oxidant stress
increased the expression of miRNA101c that downregulated Tet1
expression in HSCs, which in turn reduced the number and
function of terminally differentiated innate immune cells17. Thus,
these changes in terminally differentiated cells are actually pre-
determined at the level of HSCs.
Taken together, these ﬁndings lead to a potentially novel
paradigm that T2DM may epigenetically “preprogram” HSCs to
reduce their differentiation towards monocytes and increase their
polarization towards M1 macrophages and thereby negatively
impact wound repair. However, there are two critical links
missing in this hypothesis. First, even under conditions of normal
wound healing, the evidence for a mechanism(s) that regulates
monocyte tissue inﬁltration and the dynamics of their M1/M2
polarization is scarce. Second, the mechanisms by which T2DM
reduces monocyte/macrophage tissue inﬁltration and their M1/
M2 polarization remain unknown.
This study hypothesizes that T2D impairs wound healing by
inducing oxidant stress-dependent epigenetic modiﬁcations in
HSCs that reduce HSC differentiation towards monocytes/mac-
rophages and disrupt the balance in M1/M2 polarization during
the three phases of wound healing. In order to test our hypoth-
esis, we generated a chimeric mouse model in which hemato-
poiesis was reconstituted in lethally irradiated WT recipient mice
with HSCs from either db/db or WT mice. Here, we show for the
ﬁrst time that T2DM induces an HSC-autonomous mechanism
that causes impaired wound healing. Speciﬁcally, T2DM causes a
Nox-2-induced oxidant stress in HSCs that decreased microRNA
let-7d-3p, which, in turn, directly increased the expression of
DNA methyltransferase 1 (Dnmt1), a key enzyme mediating
DNA methylation. Dnmt1-dependent repressive modiﬁcations
reduced the expression of Notch1, PU.1, and Klf4 genes that are
central in the differentiation of HSCs towards monocytes/mac-
rophages. From a larger perspective, these novel ﬁndings reveal a
new mechanism that regulates inﬂammation: T2DM induces
changes in gene expression in HSCs that reduces the number and
function of terminally differentiated inﬂammatory cells.
Results
T2DM reduces the differentiation of HSCs towards macro-
phages. Diabetes impairs wound healing thereby making patients
with T2DM susceptible to chronic non-healing wounds that often
culminate in limb amputations18. We found that the wound
closure rates in T2D mice (db/db mice or WT mice fed high fat
diet (HFD)) were signiﬁcantly slower than those in WT mice
(Fig. 1a, b; Supplementary Fig. 1a). Histological analysis revealed
a longer distance between epithelial tips and a longer distance
between the edges of the panniculus carnosus in T2D wound
tissues at days 3, 7, and 14 after wound induction (Fig. 1c, d, f),
suggesting that the re-epithelialization and wound contraction
were signiﬁcantly impaired in T2D mice. Furthermore, the
wound tissues from T2D mice showed much less granulation
tissue, resulting in a thinner and more fragile epithelium (Fig. 1e,
f). Revascularization was also reduced in the wounds of T2D
mice, as measured by artery and total vessel density (Fig. 1g, h, i).
These results indicate that wound healing kinetics are sig-
niﬁcantly impaired in T2D mice.
Monocytes and macrophages are the major cellular compo-
nents that promote wound healing. Both the proportion and
absolute number of CD115+CD11b+monocytes were signiﬁcantly
reduced in the bone marrow of db/db and HFD mice (Fig. 2a, b, c;
Supplementary Fig. 1b). We also measured other terminally
differentiated blood cells derived from hematopoietic cells. With
the exception of an increase in red blood cells, T cells, B cells, and
granulocytes numbers were not signiﬁcantly different in db/db
mice (Supplementary Fig. 1c). Following the induction of
cutaneous wounds, total macrophage inﬁltration in db/db mice
was signiﬁcantly lower on day 3 (inﬂammatory phase) and day 7
(new tissue formation phase), but signiﬁcantly greater on day 14
(tissue remodeling phase) than in WT mice (Fig. 2d, e;
Supplementary Fig. 2).
In addition, we compared the dynamic changes in M1/M2
polarization during the three phases of wound healing in WT and
db/db mice. Both M1 and M2 macrophages were signiﬁcantly
reduced during the inﬂammatory phase in db/db mice (Fig. 2f).
During the new tissue formation phase, M1 macrophages in the
wounds of db/dbmice were increased to a level much greater than
those in the wounds of WT mice, while M2 macrophages
remained at very low levels (Fig. 2g; Supplementary Figs. 2 and 3).
In the remodeling phase, M1 macrophages were still at a
signiﬁcantly greater concentration in the wounds of db/db mice,
while M2 macrophages were at a level equivalent to the wounds
of WT mice (Fig. 2h).
In order to test the hypothesis that T2DM causes an HSC-
autonomous defect that impairs wound closure kinetics by
dysregulation of HSC lineage speciﬁcation towards monocytes
and macrophage polarization, we investigated wound closure
kinetics in a chimeric model whereby hematopoiesis was
reconstituted in lethally irradiated WT recipient mice with HSCs
from either db/db or WT mice. The wound closure rates in WT
mice were signiﬁcantly delayed in the recipients reconstituted
with db/db HSCs (Fig. 3a, b). We also observed a signiﬁcant
decrease in the rates of re-epithelialization (Fig. 3c, f; Supple-
mentary Fig. 4a), wound contraction (Fig. 3d, f; Supplementary
Fig. 4a) and revascularization (Supplementary Fig. 4b, c, d), as
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well as a signiﬁcant decrease in granulation tissue (Fig. 3e, f;
Supplementary Fig. 4a). The recipients reconstituted with db/db
HSCs also recapitulated the defects in monocyte and macrophage
frequency (Fig. 3g, h; Supplementary Fig. 5a, b) as well as the
skewed M1 polarization of macrophages in wounds (Fig. 3i, j, k;
Supplementary Fig. 5c, d). No change was found in T cells, B cells,
granulocytes and red blood cells (Supplementary Fig. 4e). These
results indicate that T2DM reduces the differentiation of HSCs
towards monocytes/macrophages, and skews their polarization
towards the M1 phenotype in an HSC-autonomous manner that
results in a pro-inﬂammatory environment that impairs wound
healing kinetics.
T2DM induces Nox-2-dependent upregulation of Dnmt1 in
HSCs. In previous studies, our group has shown that cardiovas-
cular risk factors such as hypercholesterolemia, increases HSC
oxidant stress17. Similarly, HSCs from T2D mice had signiﬁcantly
greater oxidant stress than HSCs from WT mice, as shown by the
increased DCF-DA staining (Fig. 4a; Supplementary Fig. 6a). N-
acetylcysteine (NAC) supplementation reversed the oxidant stress
and restored the monocyte concentration in the bone marrow of
db/db mice (Fig. 4a, b).
The Nox family of NADPH oxidases is an important source of
reactive oxygen species19. Among them, Nox-1, Nox-2, and Nox-
4 have been reported to be expressed in HSCs20,21. We observed
signiﬁcantly increased Nox-2 and Nox-4 expression in HSCs
from db/db mice (Fig. 4c; Supplementary Fig. 6b, c). The
inhibition of Nox-2 and Nox-4 reduced the oxidant stress in
HSCs from db/db mice (Fig. 4d, e). Since Nox-2 induced a much
higher level of oxidant stress in HSCs from db/db and HFD mice
(Fig. 4d, e; Supplementary Fig. 6b), we focused on identifying the
role of Nox-2 in HSC differentiation towards monocytes/
macrophages in db/db mice.
DNA methylation plays an important role in HSC commit-
ment to lymphoid and myeloid lineages. We have recently shown
that hypercholesterolemia causes HSC oxidant stress, which in
turn induces an epigenetic mechanism that dysregulated HSC
lineage commitment17. DNA methylation of CpG nucleotides, a
key epigenetic modiﬁcation, is established and maintained by a
family of DNA methyltransferases (Dnmts): Dnmt1, Dnmt3a,
and Dnmt3b22. We found that Dnmt1 was consistently
upregulated in HSCs from both db/db and HFD mice, while
Dnmt3b was only increased in HSCs from db/db mice (Fig. 4f;
Supplementary Fig. 7a). Dnmt1 mRNA and protein levels were
also increased in bone marrow monocytes and wound macro-
phages (Supplementary Fig. 7b, c, d). The inhibition of Nox-2 or
the treatment with NAC both restored the expression of Dnmt1
in db/db HSCs to a level comparable to that in WT HSCs, but did
not change the mRNA or the protein levels of Dnmt3a and
Dnmt3b (Fig. 4g, h). Consistent with the upregulation of Dnmt1,
the total DNA methylation status in db/db HSCs was higher than
in WT HSCs (Supplementary Fig. 7e). These results indicate that
T2DM upregulates the expression of Dnmt1 and Dnmt3b.
However, only Dnmt1 was upregulated by Nox-2-dependent
oxidant stress.
Let-7d-3p mediates the upregulation of Dnmt1 in T2D HSCs.
In order to identify the mechanism regulating Dnmt1 expression
in T2D HSCs, we next investigated the role of microRNAs, which
are non-coding RNAs that regulate gene expression by binding to
the 3′ untranslated region (UTR) of protein coding genes23. To
identify microRNAs that are regulated by T2DM, we performed a
microRNA microarray analysis of HSCs from WT and db/db
mice. Among the differentially expressed microRNAs, Let-7d-3p,
which is predicted to directly target Dnmt1, showed a signiﬁcant
oxidant stress-dependent downregulation in HSCs from db/db
mice (Fig. 5a; Supplementary Fig. 8). To determine if let-7d-3p
binds directly to Dnmt1, we cloned the mouse Dnmt1 3′ UTR
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region (labeled as Dnmt1 in Fig. 5b) and determined the luciferase
activity in HEK293T cells transfected with let-7d-3p mimic. Let-
7d-3p signiﬁcantly repressed the luciferase activity when we used
an intact 3′ UTR construct, but did not affect the luciferase activity
when the binding site of let-7d-3p in Dnmt1 3′ UTR region was
mutated (labeled as Dnmt1 M1 and Dnmt1 M2) (Fig. 5b). In
addition, a let-7d-3p inhibitor increased Dnmt1 expression in WT
HSCs, while let-7d-3p mimic decreased Dnmt1 expression in db/
db HSCs (Fig. 5c, d, e, f). Taken together, these results provide
compelling evidence that the reduced level of let-7d-3p directly
mediates the increased expression of Dnmt1 in HSCs.
Upregulation of Dnmt1 in T2D HSCs impairs wound healing.
We next sought to analyze the role of Dnmt1 in HSC differ-
entiation towards monocytes. The expression of Dnmt1 in db/db
HSCs was downregulated following the addition of an shRNA
against Dnmt1 (Fig. 6a; Supplementary Fig. 9a, b). Under in vitro
conditions, the knockdown of Dnmt1 in db/db HSCs consistently
increased their differentiation towards monocytes/ macrophages
(Supplementary Fig. 9c, d). WT recipients reconstituted with
Dnmt1-knockdown db/db HSCs showed a signiﬁcantly higher rate
of wound healing than WT recipients reconstituted with db/db
HSCs (Fig. 6b, c, d, e). In WT mice reconstituted with Dnmt1-
knockdown db/db HSCs, the inﬁltration of monocytes/macro-
phages, as well as their M1/M2 polarization throughout the three
phases of wound healing, were restored to levels comparable to
those in WT mice reconstituted with WT HSCs (Fig. 6f, g, h, i).
These ﬁndings indicate that sustained upregulation of Dnmt1
expression in HSCs mediates the deleterious effects of T2DM on
wound healing by inhibiting their differentiation towards mono-
cytes/macrophages and skewing them toward M1 polarization.
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Dnmt1 knockdown in HSCs increases wound healing in T2D
mice. In order to determine in vivo if Dnmt1-knockdown HSCs
from T2D mice rescue normal wound healing, we transplanted
Dnmt1-knockdown db/db HSCs into lethally irradiated T2D
recipients, and then induced wounds 2 months after HSC
transplantation. We found that the wound closure rate was sig-
niﬁcantly increased in T2D recipients transplanted with either
WT HSCs or Dnmt1-knockdown db/db HSCs. Meanwhile, the
most impaired wound closure rate was observed in db/db reci-
pients transplanted with db/db HSCs (Supplementary Fig. 10a, b).
Histological analysis also showed that the transplantation of
Dnmt1-knockdown db/db HSCs signiﬁcantly improved re-
epithelialization (Supplementary Fig. 11a, d), wound contrac-
tion (Supplementary Fig. 11b, d) and revascularization
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(Supplementary Fig. 4f, g, h), as well as signiﬁcantly increased
granulation tissue (Supplementary Fig. 11c, d). These ﬁndings
indicate that the transplantation of autologous Dnmt1-
knockdown HSCs from T2D mice may provide a potential
therapeutic option for T2DM patients.
Hyperinsulinemia impairs the differentiation of human HSCs.
Insulin resistance and the consequent hyperinsulinemia is a key
feature of T2DM. Hyperinsulinemia-induced oxidant stress
impairs the function of stem and progenitor cells24,25. In in vitro
experiments we found that hyperinsulinemia reduced human
HSC differentiation towards macrophages (Supplementary
Fig. 12a, b). In addition, hyperinsulinemia skewed human mac-
rophages towards M1 polarization (Supplementary Fig. 12c).
Hyperinsulinemia also increased the expression of NOX-2 and
DNMT1 in human HSCs (Supplementary Fig. 12d). These
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ﬁndings suggest that hyperinsulinemia impairs the differentiation
of human HSCs towards monocytes/macrophages by oxidant
stress-dependent upregulation of DNMT1.
Upregulated Dnmt1 in T2D HSCs represses Klf4, PU.1, and
Notch1. Transcription factors play a major role in the regulation
of HSC lineage commitment. Among them, PU.1 and Klf4 were
reported to guide monocyte and macrophage subtype-speciﬁc
programs26–31, while Notch1 was shown to be an important
extrinsic regulator of myeloid commitment that targets the
transcription factor PU.132–34. We found that the expression of
Notch1, PU.1, and Klf4 in HSCs from T2D mice was signiﬁcantly
decreased in an oxidant stress-dependent manner (Fig. 7a).
Furthermore, knocking down Dnmt1 increased the expression of
Notch1, PU.1, and Klf4 in db/db HSCs (Fig. 7b). These results
suggest that oxidant stress-dependent upregulation of Dnmt1 in
HSCs from T2D mice-induced repressive modiﬁcations of Klf4,
PU.1, and Notch 1.
To ascertain the pathological signiﬁcance caused by the
decrease in Notch1, PU.1, and Klf4 on the differentiation and
polarization of monocytes and macrophages, we knocked down
the expression of all three genes in WT HSCs. Knockdown of
Notch1, PU.1, and Klf4 reduced WT HSC differentiation towards
monocytes/macrophages (Fig. 7c, d). These results indicate that
Dnmt1-dependent downregulation of Notch1, PU.1, and Klf4 in
HSCs is likely responsible for the attenuation of monocyte/
macrophage differentiation in T2D mice, at least under in vitro
conditions.
Knockdown of Klf4 in WT HSCs skewed monocyte polariza-
tion toward the M1 phenotype (Fig. 7e). This ﬁnding is consistent
with a previous study that showed myeloid Klf4 deﬁciency
increased pro-inﬂammatory M1 macrophages and facilitated the
inﬂammatory response during wound healing35,36. These results
support our ﬁndings that downregulation of Klf4 in T2DM HSCs
is most likely responsible for the polarization towards M1
macrophages. In addition, this supports the novel concept that
changes in gene expression of progenitor and terminally
differentiated inﬂammatory cells can be “preprogramed” at the
level of HSCs.
Dnmt1 induces DNA hypermethylation of Notch1, PU.1, and
Klf4. To test if the upregulation of Dnmt1 increases the repressive
modiﬁcation of the genes critical in the differentiation of HSCs
towards monocytes/macrophages, we measured the DNA
methylation status of Notch1, PU.1, and Klf4 genes in HSCs from
WT and db/db mice. Pyrosequencing analysis showed a sig-
niﬁcant increase in DNA methylation in Notch1, PU.1, and Klf4
in db/db HSCs. On the other hand, increased expression of let-7d-
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3p and knockdown of Dnmt1 in db/db HSCs decreased the
methylation of Notch1, PU.1, and Klf4 (Fig. 8a; Supplementary
Figs. 13 and 14). These results suggest that Dnmt1-induced DNA
methylation inhibits the expression of Notch1, PU.1, and Klf4 in
HSCs from db/db mice.
Dnmt1 has been shown to contribute to the regulation of
histone modiﬁcations. Indeed, ablation of Dnmt1 reduces
dimethylation (H3K9me2) and trimethylation (H3K9me3) at
H3K9 and increases H3K9 acetylation (H3K9ac)37,38. Therefore,
we performed ChIP-PCR to test if H3K9 methylation silences the
expression of Klf4, PU.1, and Notch 1. Both the dimethylated
(H3K9me2) and trimethylated (H3K9me3) histone proteins were
increased in the promoters of Klf4, PU.1, and Notch1 genes in
HSCs from T2D mice (Fig. 8b; Supplementary Fig. 15a).
However, no difference in H3K9Ac was recorded in the three
genes in WT or T2DM HSCs (Supplementary Fig. 15b). Both
knockdown of Dnmt1 and increased expression of let-7d-3p in
db/db HSCs decreased the histone methylation levels (Supple-
mentary Figs. 15b; Fig. 16). These ﬁndings indicate that the
oxidant stress-induced inhibition of let-7d-3p leads to an
upregulation of Dnmt1 which in turn increases the repressive
H3K9 methylation and decreases the expression of Notch1, PU.1,
and Klf4 in HSCs from T2D mice.
Discussion
Traditionally, wound healing has been described as a process that
requires a ﬁnely tuned orchestrated recruitment of terminally
differentiated cells by different external cues to wound sites.
Although it is well established that this process is delayed in
T2DM, to date, the mechanism(s) responsible for such a delay
Days post wounding
b
0
20
40
60
80
100
120
0 3 7 14 0 3 7 1421 24 28 35
*
*
*
*
* *
#
*#
*#
*#
W
ou
nd
 c
lo
su
re
 r
at
e
WT HSCWT
db/db HSCWT
db/db HSC+shDnmt-1 WT 
WT HSCWT
db/db HSCWT
db/db HSC+shDnmt-1 WT 
a
0
0.5
1
1.5
2
2.5
*
*#
R
el
at
iv
e 
D
nm
t-1
 g
en
e 
ex
pr
es
si
on
db/db HSC+shDnmt-1
WT HSC
db/db HSC
0
1
2
3
4
5
6
7
D
is
ta
nc
e 
be
tw
ee
n 
ep
ith
el
ia
l t
ip
s
(×
10
3  
μm
)
Days post wounding
*
*
*
c
#
#
#
0
1
2
3
4
5
6
7
D
is
ta
nc
e 
be
tw
en
 e
nd
s 
of
pa
nn
ic
ul
us
 c
ar
no
su
s 
(×
10
3 
μm
)
0 3 7 14
Days post wounding
0 3 7 14
Days post wounding
3 7 14
Days post wounding
*
*
*
d
#
#
#
0
2
4
6
8
10
12
14
16
18
G
ra
nu
la
tio
n 
tis
su
e 
(×
10
5  
μm
2 )
*
*
*
e
#
#
#
#
f
0
5
10
15
20
25
30
35
40
*
*
*
#
#
%
 F
4/
80
+
 C
D
11
5+
C
D
11
b+
  c
el
ls
db/db HSC+shDnmt-1WT db/db HSCWTWT HSCWT
%
 d
b/
db
 H
S
C
+
sh
D
nm
t-
1
W
T
 v
s.
 d
b/
db
 H
S
C

W
T
g
Day 3–80
–30
20
70
120
170
%
 d
b/
db
 H
S
C
+
sh
D
nm
t-
1
W
T
 v
s.
 d
b/
db
 H
S
C

W
T
–80
–30
20
70
120
170
%
 d
b/
db
 H
S
C
+
sh
D
nm
t-
1
W
T
 v
s.
 d
b/
db
 H
S
C

W
T
–80
–30
20
70
120
170
* * * *
h
Day 7
*
*
*
*
M1 marker
M2 marker
i
Day 14
* *
*
*
#
TNFα
iNOS
lL12
lL10
Arginase 1
CD206
Fig. 6 Knockdown of Dnmt1 in db/db HSCs increases wound closure rate. a qRT-PCR quantiﬁcation of Dnmt1 expression (n= 6, *p< 0.05 vs. WT HSC,
#p< 0.05 vs. db/db HSC). b Wound closure rate measurement (n= 8, *p< 0.05 vs. WT HSC→WT, #p< 0.05 vs. db/db HSC→WT). c–e Histological
quantiﬁcation of distance between epithelial tips/ends of panniculus carnosus and granulation tissue (n= 4, **p< 0.05 vs. W T HSC→WT, #p< 0.05 vs.
db/db HSC→WT). f Quantiﬁcation of macrophage concentration in the cutaneous wounds by ﬂow cytometry (n= 6, *p< 0.05 vs. WT HSC→WT, #p<
0.05 vs. db/db HSC→WT). g–i Quantiﬁcation of M1/M2 polarization in cutaneous wounds by ﬂow cytometry. (n= 6, #p< 0.05 vs. db/db HSC→WT).
Results are expressed as means± SEM. One way ANOVA was used for a–f. Two-tailed unpaired Student’s t test was used for g–i
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-017-02425-z
8 NATURE COMMUNICATIONS |  (2018) 9:33 |DOI: 10.1038/s41467-017-02425-z |www.nature.com/naturecommunications
had not been well deﬁned. In this study, we show that T2DM
impairs wound healing through an HSC-autonomous mechanism
whereby a Nox-2-dependent increase in HSC oxidant stress
decreases microRNA let-7d-3p, which, in turn, directly increases
the expression of Dnmt1. This increase in Dnmt1 expression
leads to the downregulation of the genes responsible for HSC
differentiation towards monocytes/macrophages, and conse-
quently reduces macrophage inﬁltration and skews the polariza-
tion towards M1 macrophages in the wounds of T2D mice.
One of the key ﬁndings of this study is that T2DM induces
pathological HSC oxidant stress that can reduce the number and
function of terminally differentiated inﬂammatory cells. In a
recent study, Nox-2 has been shown to contribute to
hyperinsulinemia-induced redox imbalance in endothelial cells39.
Nox-2-induced oxidant stress has also been shown to play a
critical role in insulin resistance-related endothelial cell dys-
function that eventually leads to vascular occlusive disease40. Our
results show that oxidant stress-induced epigenetic mechanisms
lead to changes in HSC gene expression that are carried down
through progenitor cells to terminally differentiated cells. This
supports the concept that changes in gene expression of term-
inally differentiated inﬂammatory cells are actually epigenetically
“preprogrammed” at the HSC level.
Thus, the concentration of macrophages in wounds of T2D
mice is signiﬁcantly lower than that in WT mice in early
inﬂammatory and new tissue regeneration phases, but remains at
signiﬁcantly greater levels in the tissue remodeling phase. In
agreement with previous ﬁndings, our study showed that M1
macrophages comprise the absolute majority of macrophages in
the wounds of T2D mice6–8.
Moreover, our study is the ﬁrst to show that Dnmt1 in
HSCs functions as a critical determinant in their differ-
entiation towards monocytes and macrophages as well as in
their polarization. Indeed, we show that Dnmt1 was speciﬁ-
cally upregulated in HSCs from both db/db and HFD mice
and this supports the fact that the impairment of wound
healing is not due to other metabolic abnormalities of db/db
mice. The inhibition of Dnmt1 in HSCs from T2D mice
increased the differentiation from HSCs towards monocytes/
macrophages and restored the balance of M1/M2 polarization
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in vivo. More importantly, the transplantation with Dnmt1-
knockdown HSCs from db/db mice restores the rate of wound
healing in T2D recipients to levels similar to those seen in
WT mice. These novel ﬁndings show that the dysregulated
lineage priming of HSCs in T2D mice is the central under-
lying cause of impaired wound healing.
Notch1, PU.1, and Klf4 have been shown to be the most critical
regulators of the differentiation and polarization of monocytes/
macrophages. In our study, Notch1, PU.1, and Klf4 were down-
regulated in HSCs from T2D mice. As is known, Notch1 deﬁ-
ciency leads to decreased macrophage recruitment and TNFα
expression in response to wounding34. Klf4 is a downstream
target gene of PU.1 and Notch 141,42 and induces an M2 phe-
notype while inhibiting the M1 phenotype. Klf4 deﬁciency in
myeloid cells results in delayed wound healing and increased pro-
inﬂammatory M1 macrophages36. In agreement with these ﬁnd-
ings, the T2DM-induced inhibition of Notch1, PU.1, or Klf4 in
HSCs reduced the differentiation and polarization of monocytes/
macrophages under in vitro conditions.
The mechanism by which Dnmt1 regulates the expression of
Notch1, PU.1, and Klf4 is through the modiﬁcation of their
methylation status. Indeed, we found that the DNA methylation
status of Notch1, PU.1, and Klf4 increased in HSCs from db/db
mice. Furthermore, Dnmt1 can also participate in the regulation
of histone modiﬁcations37,38. ChIP-PCR showed that the dime-
thylation (H3K9me2) and trimethylation (H3K9me3) of H3K9
were increased in Klf4, PU.1, and Notch1 genes in HSCs from
T2D mice. When Dnmt1 was inhibited, these repressive mod-
iﬁcations at H3K9 were reduced, and the expression of these
genes was restored in HSCs from T2D mice. These ﬁndings
indicate that the upregulation of Dnmt1 increased the repressive
histone modiﬁcations in Notch1, PU.1, and Klf4, thereby inhi-
biting the expression of these genes in HSCs from T2D mice.
Moreover, the identiﬁcation of the let-7d-3p-dependent reg-
ulation of Dnmt1 in type 2 diabetic HSCs, which regulates the
genes responsible for HSC differentiation towards monocytes as
well as their M1/M2 polarization, creates an excellent opportunity
for the development of biological therapeutics to restore normal
wound healing in people with T2DM. In addition, two inde-
pendent studies show that the let7 family modulates angiogenesis
and contributes to the dysfunction of db/db type 2 diabetic bone
marrow-derived angiogenic cells43,44. We now show the
mechanism responsible for these ﬁndings.
Finally, based on in vitro experiments, we showed that normal
human HSCs have the same response to hyperinsulinemia-
induced Nox-2-dependent oxidant stress. Indeed, hyper-
insulinemia increased the expression of Nox-2 and Dnmt1 in
human HSCs. This led to a reduction of human HSC differ-
entiation towards macrophages and skewed human macrophages
towards M1 polarization.
Taken together, these insights into the mechanism by which
T2DM impairs wound healing open multiple avenues to new
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promising techniques to restore normal wound healing and
thereby reduce the risk of amputation in people with T2DM.
Methods
Animals. In total, 8–12 weeks old male C57BL/6J wild type (WT) and B6.BKS(D)-
Leprdb/J (db/db) mice were used in the studies. All mice were purchased from
Jackson Laboratories and were maintained in mouse barrier facilities. Care and use
of mice was in accordance with NIH guidelines and the Institutional Animal Care
and Use Committee of the University of Massachusetts Medical School approved
all protocols and granted us permission to perform all the experiments described in
this manuscript. db/db and WT mice were fed standard chow diet (5.4 g/100 g diet,
0% cholesterol) and HFD mice were generated by feeding C57BL/6J mice a HFD
(60% fat calories; Research Diet, New Brunswick, NJ). NAC was given for 8 weeks
(150 mg/kg/day via drinking water).
Induction of cutaneous wounds. Cutaneous wounds were induced as described in
Luo et al.14. In brief, mice were anesthetized using isoﬂurane. The dorsal surface
was shaved, washed with povidone-iodine solution and cleaned with an alcohol
swab. Two wounds, one on each side of the midline, were patterned on the shaved
dorsum of the mice using a sterile 6-mm punch biopsy tool (Miltex, Inc. York, PA
17402, USA). A silicone stent was secured around the perimeter of the wound. To
improve adherence of the wound dressing, tincture benzoin was applied to the
perimeter of the wound and allowed to dry. Finally, the wound was covered with a
transparent, bio-occlusive dressing (Opsite, Smith and Nephew Medical Limited,
Hull, England) thereby creating a moist wound chamber environment. Following
surgery, the mice were placed in individual cages, and allowed to fully recover from
the anesthesia. The animals were housed in the institutional animal facility.
Morphometric analysis of wounds. Wound closure rate was calculated by mac-
roscopic quantiﬁcation and histological analysis. For macroscopic quantiﬁcation,
wound photographs were taken with a Nikon camera at the indicated time points
and the wound areas were measured by imageJ software. For histological analysis,
5 µm parafﬁn sections were stained with hematoxylin–eosin (H&E). Images were
taken using a NikonEclipse 90i microscope. The distances between the epithelial
tips/the edges of panniculus carnosus and granulation tissue were measured by
NIS-Element AR analysis.
Immunohistochemistry of wounds. Immunohistochemical staining was per-
formed on 5 µm cryosections of day 7 wounds. Brieﬂy, 5 µm cryosections were
ﬁxed either in 4% paraformaldehyde (CD144 and SMC vessels) or in acetone (F4/
80 macrophages) and blocked with 5% goat serum. For macrophage staining pri-
mary antibodies, we used rat mAbs against F4/80(1:40, AbD serotec MCA497G,
clone:CI: A3-1), rabbit mAbs against iNOS (1:800, Novus biologicals NBP1-33780,
clone: K13-A), rat mAbs against TNFα (1: 10, AbD serotec MCA1488, clone: MP6-
XT22), rabbit pAbs against CD206 (1:400, Santa Cruz sc-48758), and rabbit pAbs
against Arginase (1:400, Novus biologicals NBP1-32731). For secondary antibodies,
we used Alexa Fluor 488 goat anti-rat IgG(1:500, Invitrogen A11006), Alexa Fluor
555 goat anti-rat IgG(1:500, Invitrogen A21434), or Alexa Fluor 555 goat anti-
rabbit IgG (1:500, Invitrogen A21428). For vessel staining, we used CD144 (1:40,
BD pharmingen 550548) and FITC conjugated α-smooth muscle actin (α-SMA,
1:2000, Sigma-Aldrich F3777, clone:1A4). Immunoﬂuorescent images were taken
using a Zeiss microscope axiocam at ×200 magniﬁcation.
Hematopoietic stem cell sorting and transplantation. Whole bone marrow cells
were ﬂushed out from femurs and tibialis. Bone marrow cells were stained with
antibodies for the identiﬁcation of HSCs (c-Kit+Sca1+lineage-CD90.1lo/−). The
antibodies used were: c-Kit (1:50, eBioscience 12–1171, clone: 2B8), Sca-1 (1:50,
eBioscience 11–5981, clone: D7), CD90.1 (1:50, eBioscience 45–0900, clone:HIS51)
and a lineage cocktail antibody (1:50, BD Bioscience 558074). As for the gating
strategy for ﬂow cytometry, we ﬁrst gated on single, viable cells and eliminated any
debris, dead cells and clumps or doublets. We then drew gates on the c-Kit-
positive/Sca1-positive/lineage-negative/CD90.1low-negative population for HSC
sorting. Cell sorting was performed on a MoFlow or FACSAria cell sorter.
To reconstitute the hematopoiesis, the recipient mice were lethally irradiated
(with a split dose of 1100 Gy) and 3,000 HSCs were transplanted to each recipient
by retro-orbital injection. For lentiviral-shRNA transfected HSCs, around 10,000
cells were transplanted to each recipient.
Lentivirus conjugated shRNA transduction. Lentiviral-shRNA constructs were
tagged with GFP and purchased from the RNAi core facility at UMASS Medical
School. Lentiviral particles were generated in 293 T cells, which were purchased
from ATCC (CRL-3216). Sorted HSCs were incubated with lentiviral supernatant
with 8 µg/ml polybrene at 37 °C for 20–30 min and then spun down at 25 °C,
3000 rpm for 1.5 h. The supernatant was then replaced with lentiviral supernatant
and HSC medium with 4 µg/ml polybrene in 6-well plates and incubated overnight.
The medium was replaced after 24 h and the cells were cultured for an additional
1–2 days. Finally, GFP positive cells were puriﬁed by FACS sorting.
HSC-induced differentiation towards macrophages. HSCs were cultured in
complete RPMI 1640 medium (20% FBS, 100 U/ml penicillin, 100 U/ml strepto-
mycin, 50 µg/ml beta-mercaptoethanol, 1% Glutamax (GIBCO), 1% nonessential
amino acid (GIBCO), and 1% sodium pyruvate(GIBCO)) supplemented with
50 ng/ml SCF, 10 ng/ml TPO, and 10 ng/ml Flt3 with either 6 ng/ml IL-3 and
10 ng/ml IL-6, or 10 ng/ml M-CSF or 40 ng/ml M-CSF (Peprotech). After 6 days,
cells were induced to differentiate towards M1/M2 macrophage by changing the
medium to the M1 induction medium (HSC basic medium, 5% FBS, 50 ng/ml LPS
and 5 ng/ml IFNγ) or the M2 induction medium (HSC basic medium, 5% FBS,
10 ng/ml IL-4) overnight. Cells were then collected and stained with macrophage
markers (F4/80 (1:50, eBioscience 12–4801, clone:BM8), CD115(1:50, eBioscience
17-1152-82, clone: AFS98), CD11b (1:50, eBioscience 45-0112-82, clone:M1/70)),
M1 macrophage markers (TNFα(1:50, eBioscience 17-7321-81,clone:MP6-XT22),
iNOS (1:50, BD Bioscience 610331), IL-12(1:50, eBioscience 45-7123-80, clone:
C17.8)), or M2 macrophage markers (Arginase 1(1:400, Novus biologicals NBP1-
32731), CD206(1:50, Biolegend 141708, clone:C068C2), IL-10(1:50, eBioscience 11-
7101-82, clone:JESS-16E3)). Stained cells were run through a BD FACSCalibur ﬂow
cytometer and data were analyzed using the FlowJo software. All the cytokines were
purchased from Peprotech and all the antibodies were purchased from BD
Biosciences.
Macrophage concentration and M1/M2 macrophage identiﬁcation. Wound
cutaneous samples were collected by 2 mm biopsy punch and minced to 2 mm2
sections on ice followed by digestion with dispase (Roche, overnight at 4 °C), and
hyaluronidase (Sigma) and Collagenase (Roche, 2 h at 37 °C). Single-cell suspen-
sions (106 cells/µl) were incubated with rat anti-mouse CD16/CD32 antibody(1:50,
eBioscience 14-0161-82, clone:93) at 4 °C for 15–30 min to minimize nonspeciﬁc
staining of leukocyte Fc receptors. After incubation, cells were washed once and
resuspended in FACS buffer for antibody staining. For macrophage identiﬁcation,
we used F4/80, CD115, and CD11b antibodies. For M1 macrophage identiﬁcation,
we used TNFα, iNOS, and IL12 antibodies. For M2 macrophage identiﬁcation, we
used Arginase 1, CD206, and IL10 antibodies. The source and dilution of all the
antibodies were the same as described above. Stained cells were processed on a BD
FACSCalibur ﬂow cytometer and analyzed using FlowJo software.
Quantitative real-time PCR. RNA was extracted from cells using RNAqueous
Micro Kit as directed by the manufacturer (Ambion). cDNA synthesis was per-
formed using Superscript III reverse transcriptase as directed by the manufacturer
(Invitrogen). Quantitative real-time PCR (qRT-PCR) was performed using SYBR
Green Mix (Bio-Rad) on an Eppendorf Master Cycler. Primers are listed in Sup-
plementary Tables 1 and 2.
Western blot analysis. Cells were homogenized in lysis buffer (50 mM N-2-
hydroxyethylpiperazine-N′-2-ethanesulfonic acid [pH 7.5], 150 mM magnesium
chloride, 1 mM ethylenediaminetetraacetic acid, 100 mM sodium chloride, 1%
NP40). Protein extracts underwent sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE) and were transferred to a nitrocellulose membrane.
The membrane was blocked with 5% milk for 1 h at RT followed by incubation
with one of the following primary antibodies overnight at 4 °C: Dnmt1 (1:1000,
Sigma D4567), Dnmt3a (1:1000, ThermoFisher MA1-91490, clone:64B814),
Dnmt3b (1:1000, ThermoFisher Scientiﬁc PA1-884), and α-tubulin(1:5000, Sigma
T6074, clone:B-5-1-2). Following washes, membranes were incubated with a spe-
ciﬁc horseradish peroxidase-conjugated secondary antibody which include anti-
mouse IgG (1:3000, Promega W4021) and anti-rabbit IgG (1:3000, Promega
W4011) for 1 h at room temperature and proteins were visualized by incubation
with ECL (ThermoFisher Scientiﬁc). Quantiﬁcation was performed using ImageJ
software. Uncropped versions of all Western Blots can be found in Supplementary
Figure 17.
Pyrosequencing. Genomic DNA was isolated by traditional phenol–chloroform
extraction and isopropanol precipitation. DNA concentration was measured using
a NanoDrop spectrophotometer. Around 500 ng genomic DNA were bisulﬁte
converted by EZ DNA methylation-Gold kit following the manufacturer’s
instructions (Zymo Research). PCR ampliﬁcation was performed using 2xHiFi
Hotstart Uracil + ready mix PCR (Kapa Biosystems). PCR and pyrosequencing
primer sets with one biotin-labeled primer were used to amplify the bisulﬁte
converted DNA. Primers were designed using PyroMark Assay Design software
version 2.0.1.15 (Qiagen). The size of the amplicons was 200 bp or less. Brieﬂy, 5 μl
master mix, 5 pmol of each primer, 20 ng genomic DNA and ultra-pure water to a
ﬁnal volume of 10 µl were mixed for each reaction and run at thermal cycling
conditions: 95 °C for 3 min and then 50 cycles: 20 s at 98 °C; 15 s at the optimized
primer-speciﬁc annealing temperature; 15 s at 72 °C and a ﬁnal extension for 1 min
at 72 °C. The ampliﬁed DNA was conﬁrmed by electrophoresis on a 2% agarose gel.
2 μl streptavidin beads (GE Healthcare, Buckinghamshire, UK), 40 μl PyroMark-
binding buffer, 10 μl PCR product and 28 μl water were mixed and incubated for
10 min on a shaking platform at 1300 rpm. Using the Biotage Q96 Vaccum
Workstation, amplicons were separated, denatured, washed, and added to 25 μl
annealing buffer containing 0.33 μM of pyrosequencing primer. Primer annealing
was performed by incubating the samples at 80 °C for 2 min and allowed to cool to
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room temperature prior to pyrosequencing. PyroGold reagents were used for the
pyrosequencing reaction and the signal was analyzed using the PSQ 96MA system
(Biotage, Uppsala, Sweden). Target CGs were evaluated by instrument software
(PSQ96MA 2.1), which converts the pyrograms to numerical values for peak
heights and calculates the methylation at each base as a C/T ratio. Primers are listed
in Supplementary Table 3.
ChIP-PCR. 1 × 106 HSCs were sorted and crosslinked with 1% formaldehyde at
room temperature for 10 min, and the reaction was stopped by adding Glycine to a
ﬁnal concentration of 0.125 M and incubating at room temperature for 5 min.
Crosslinked cells were lysed in lysis buffer and sonicated to 200–500 bp fragments
(Bioruptor, Diagenode). The sonicated chromatin was centrifuged at 4 °C for
5 min. The crosslinked DNA was immunoprecipitated with histone H3 pan,
H3K9me3, H3K9me2, or H3K9Ac antibodies (Millipore, USA) overnight at 4 °C
with rotation, DNA-Antibody complexes were bound to ChIP beads, pulled down,
washed, and then eluted from the beads. Following reversal of cross-linkage,
puriﬁed DNA was used for quantitative PCR using ChIP-PCR primers purchased
from IDT (MA, USA). Immunoprecipitation efﬁciency was calculated by nor-
malizing sample CT values against control IgG values and calculating ratios of
sample CT values relative to histone H3 values. Primers are listed in Supplementary
Table 4.
MiRNA microarray expression proﬁling. HSCs were isolated as described. Total
RNA was isolated using the mirVana miRNA isolation kit according to the
manufacturer’s instructions (Applied Biosystems). MicroRNA expression was
measured by Affymetrix miRNA 3.0 array (Affymetrix, Santa Clara, CA, USA). The
sample labeling, microarray hybridization, and washing were performed based on
manufacturer’s standard protocols. The slides were washed and stained and the
arrays were scanned by the Affymetrix Scanner 3000 (Affymetrix). The scanned
images were analyzed using Expression Console software (version 1.3.1 Affyme-
trix). The CEL ﬁles generated from the assays were analyzed using the Affymetrix
Expression Console Software. Based on our microarray results and a review of the
literature, candidate miRNAs were chosen for further validation with qRT-PCR.
All experiments were conducted in the Genomic Core Facility of the University of
Massachusetts Medical School.
qRT-PCR analysis of microRNA expression. Total RNA was isolated using the
mirVana miRNA isolation kit (Applied Biosystems). cDNA was synthesized using
the QuantiMir RT Kit small RNA quantiﬁcation system (SBI). Mouse U6 was used
as an endogenous control. The let-7d-3p mimic and inhibitor were purchased from
Life Technologies (catalog numbers 4464066 and 4464084, respectively).
miRNA target prediction. The predicted target genes of differentially expressed
miRNAs were obtained using the following tools: TargetScan v6.2, miRDB, and
Affymetrix Expression Console Software. The search was performed on the 3′-UTR
regions of target mRNAs with a p value of 0.05 deﬁning the probability distribution
of random matches set in the software with a minimum miRNA seed length of 7.
mRNA 3′-UTR cloning and luciferase reporter assay. HEK293T cells grown in
96-well plates were transfected with pmirGLO containing the Dnmt1 3′ UTR
region that includes the let-7d-3p-binding sites. The cells were co-transfected with
let-7d-3p using Lipofectamine (Invitrogen). The Fireﬂy and Renilla luciferase
activities in the cell lysates were assayed with a Dual-Luciferase Reporter Assay
System (Promega) at 48 h post-transfection. To generate the mutant variants, point
mutations in the binding sites of let-7d-3p in the 3′-UTR region of Dnmt1 were
introduced by PCR according to the site-directed mutagenesis protocol from
Agilent. The two mutants that were generated are labeled “Dnmt1 M1” and “Dnmt1
M2”.
Analysis of intracellular ROS by DCF-DA staining. Cells were resuspended in
PBS and incubated with 5 µM DCF-DA (Sigma) for 30 min at 37 degrees in the
dark. Cells were then washed twice with PBS and analyzed on a BD FACSCalibur
analyzer (excitation wavelength 492–495 nm; emission wavelength 517–527 nm).
The resulting data was analyzed using FlowJo software.
Dot blotting. Dot blotting was performed following the method described in
Hainer et al.45. Brieﬂy, serial dilutions of genomic DNA starting at 300 ng were
denatured at 95 °C for 10 min, then put on ice immediately for 10 min. Denatured
DNA samples were spotted onto Amersham Hybond N + nylon membrane (GE
Healthcare, Uppsala, Sweden) and the membranes were UV crosslinked. The
membrane was incubated in 0.1% SDS overnight, blocked with 5% nonfat milk and
3% BSA for 2 h, incubated with anti-5mC (1:1000, Eurogentec BI-MECY, RRID:
AB_2616058) for 1 h, washed three times with PBS-T, incubated with HRP con-
jugated anti-mouse secondary (1:10,000, Bio-Rad, Hercules, CA, USA, 170–6516,
RRID:AB_11125547) for 1 h, washed three times with PBS-T, and detected with
enhanced chemiluminescence. For loading, gDNA samples were diluted simulta-
neously, spotted directly onto Amersham Hybond N + nylon membrane (GE
Healthcare) and the membranes were UV crosslinked. Membranes were incubated
with 0.2% methylene blue for 5 min and washed ﬁve times with water.
Human HSCs. Fresh whole human bone marrow was purchased from ALL Cells
(1301 Harbor Bay Pkwy #200, Alameda, CA 94502). Mononuclear cells were iso-
lated with Ficoll-Paque PLUS (1.077 density) and CD34 + cells were sorted and
cultured in RPMI 1640 supplemented with cytokines (50 ng/ml SCF, 50 ng/ml Flt3,
20 ng/ml TPO, 20 ng/ml IL-3, 20 ng/ml IL-6) with or without 174 nM (equal to 1.0
µg/ml) insulin for 48 h. For induced differentiation towards macrophages, 1.0 × 105
HSCs were seeded in 6-well plates with 1.5 ml medium containing 25 ng/ml M-CSF
for 3 days. Fresh medium was added every other day. For M1/M2 differentiation,
on day 3, cells were washed with PBS and RPMI1640 containing 5% FBS, 1% PS,
100 ng/ml IFNγ (for M1), or 10 ng/ml IL-4 and IL-13(for M2) was added for 24 h.
The human macrophage markers used are: CD68(1:50, eBioscience 12-0689-41,
clone:eBioY1/82 A), CD14(1:50, eBioscience 11-0149-42, clone:61D3), CD206(1:50,
eBioscience 12-2069-41, clone:19.2), CD163 (1:50, eBioscience 17-1639-41, clone:
eBioGHI/61).
Statistical analysis. All data are shown as means ± SEM. Statistical analyses were
carried out with GraphPad Prism (GraphPad Software) software. Statistical sig-
niﬁcance was evaluated by using a one way analysis of variance (ANOVA) or an
unpaired t test. Signiﬁcance was established for p values of at least <0.05.
Data availability. The data discussed in this study have been deposited in NCBI’s
Gene Expression Omnibus which is accessible through the GEO series accession
number GSE89842. All data that support the ﬁndings of this study are available
from the corresponding author upon request.
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